Financials LIVENT Nyse

Equities

LTHM

US53814L1089

Specialty Chemicals

Market Closed - Nyse Other stock markets 04:00:13 2024-01-03 pm EST			5-day change	1st Jan Change
16.51 ^USD	-8.53%		+140.60%	+120.93%

May. 15	BMO Capital Adjusts Price Target on Arcadium Lithium to $5.50 From $6, Maintains Market Perform Rating	MT
May. 10	Arcadium Lithium Applies to Cease to be a Reporting Issuer in Canada	MT

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	1,248	2,756	3,939	3,564	3,235	4,763	-	-
Enterprise Value (EV) ¹	1,386	2,981	4,067	3,617	3,299	5,157	5,466	5,289
P/E ratio	25.1 x	-145 x	7,396 x	14.6 x	4.73 x	20.4 x	9.51 x	5.41 x
Yield	-	-	-	-	-	-	-	-
Capitalization / Revenue	3.21 x	9.56 x	9.37 x	4.38 x	3.67 x	3.89 x	2.74 x	1.92 x
EV / Revenue	3.57 x	10.3 x	9.67 x	4.45 x	3.74 x	4.21 x	3.14 x	2.13 x
EV / EBITDA	13.9 x	134 x	58.5 x	9.86 x	6.57 x	10.2 x	6.76 x	3.88 x
EV / FCF	-11 x	-25.3 x	-38.5 x	30.7 x	-111 x	-18.1 x	-24.6 x	62 x
FCF Yield	-9.11%	-3.95%	-2.59%	3.26%	-0.9%	-5.52%	-4.06%	1.61%
Price to Book	2.29 x	4.87 x	5.48 x	2.78 x	0.68 x	0.75 x	0.69 x	0.67 x
Nbr of stocks (in thousands)	351,230	352,004	388,749	431,573	432,889	1,075,192	-	-
Reference price ²	3.554	7.830	10.13	8.259	7.473	4.430	4.430	4.430
Announcement Date	2/20/20	2/18/21	2/17/22	2/14/23	2/22/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	388.4	288.2	420.4	813.2	882.5	1,225	1,738	2,477
EBITDA ¹	99.8	22.3	69.5	366.7	502.5	506.1	808.7	1,362
EBIT ¹	78.9	-2.7	44.4	339	472.9	345.5	642.8	1,086
Operating Margin	20.31%	-0.94%	10.56%	41.69%	53.59%	28.19%	36.99%	43.85%
Earnings before Tax (EBT) ¹	57.8	-25.4	23.9	335.4	389	352.8	609	1,069
Net income ¹	50.2	-18.9	0.6	273.5	330.1	251.1	511.5	879.1
Net margin	12.92%	-6.56%	0.14%	33.63%	37.41%	20.49%	29.43%	35.48%
EPS ²	0.1413	-0.0540	0.001370	0.5652	1.580	0.2175	0.4657	0.8188
Free Cash Flow ¹	-126.2	-117.7	-105.5	117.8	-29.8	-284.6	-221.8	85.29
FCF margin	-32.49%	-40.84%	-25.1%	14.49%	-3.38%	-23.22%	-12.76%	3.44%
FCF Conversion (EBITDA)	-	-	-	32.12%	-	-	-	6.26%
FCF Conversion (Net income)	-	-	-	43.07%	-	-	-	9.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Announcement Date	2/20/20	2/18/21	2/17/22	2/14/23	2/22/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 S1	2024 Q3	2024 Q4	2024 S2	2025 Q1	2025 Q2
Net sales ¹	122.9	143.5	218.7	231.6	219.4	253.5	235.8	211.4	181.8	261.2	280.8	562	333	361.4	706	384.2	406.4
EBITDA ¹	27.5	53.3	95	110.8	107.6	157.4	134.5	119.7	90.9	108.8	105.4	215	131.5	152.6	262	166.5	177.9
EBIT ¹	21.1	46.9	88.6	104.2	99.3	150.6	127.5	112	82.8	91.6	84.78	164	102.9	124	174	124.7	136.8
Operating Margin	17.17%	32.68%	40.51%	44.99%	45.26%	59.41%	54.07%	52.98%	45.54%	35.07%	30.19%	29.18%	30.91%	34.32%	24.65%	32.46%	33.65%
Earnings before Tax (EBT) ¹	17	57.9	90.2	99.1	88.2	138.7	104.8	96.7	48.8	73.7	71.05	-	102.6	129.8	182	121.9	117.3
Net income ¹	7.5	53.2	60	77.6	82.7	114.8	90.2	87.4	37.7	15.6	66.42	66	82.48	102.6	115	100	111.8
Net margin	6.1%	37.07%	27.43%	33.51%	37.69%	45.29%	38.25%	41.34%	20.74%	5.97%	23.66%	11.74%	24.76%	28.39%	16.29%	26.04%	27.5%
EPS ²	0.0166	0.1164	0.1288	0.1538	0.1621	0.2286	0.1787	0.1746	0.1800	0.0100	0.0532	-	0.0682	0.0867	-	0.0800	0.0900
Dividend per Share ²	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Announcement Date	2/17/22	5/3/22	8/2/22	11/1/22	2/14/23	5/2/23	8/3/23	10/31/23	2/22/24	5/7/24	-	-	-	-	-	-	-

¹USD in Million²USD

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	138	225	127	52.9	64.4	394	703	526
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	1.381 x	10.09 x	1.833 x	0.1443 x	0.1282 x	0.7793 x	0.8688 x	0.3861 x
Free Cash Flow ¹	-126	-118	-106	118	-29.8	-285	-222	85.3
ROE (net income / shareholders' equity)	9.71%	-2.65%	4.87%	24.4%	17.7%	3.11%	4.75%	8.16%
ROA (Net income/ Total Assets)	6.62%	-2.1%	0.06%	16.7%	12.4%	5.28%	5.84%	5.85%
Assets ¹	757.9	898.2	1,070	1,638	2,652	4,760	8,756	15,031
Book Value Per Share ²	1.550	1.610	1.850	2.970	10.90	5.910	6.400	6.640
Cash Flow per Share ²	0.1600	0.0200	0.0600	0.9400	1.420	0.2600	0.4400	0.6700
Capex ¹	189	124	132	337	327	616	682	607
Capex / Sales	48.66%	43.03%	31.37%	41.43%	37.07%	50.31%	39.24%	24.51%
Announcement Date	2/20/20	2/18/21	2/17/22	2/14/23	2/22/24	-	-	-

¹USD in Million²USD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for LIVENT

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.43 USD

Average target price

7.991 USD

Spread / Average Target

+80.39%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
ECOLAB INC.	+17.07%	66.31B
SIKA AG	-0.29%	48.46B
GIVAUDAN SA	+21.61%	43.27B
FUJIFILM HOLDINGS CORPORATION	+26.72%	27.41B
EMS-CHEMIE HOLDING AG	+9.25%	19.26B
SYMRISE AG	+9.75%	16.58B
CELANESE CORPORATION	-2.14%	16.61B
ALBEMARLE CORPORATION	-15.01%	14.41B
POSCO FUTURE M CO., LTD.	-30.22%	14.02B

Other Specialty Chemicals